ArticleNutrition and metabolic insights2026
Diabetes Monitoring in Pregnant Women with Type 1 Diabetes: Capillary Blood Glucose or Interstitial Fluid Glucose? A Case Control Study.
Article in Nutrition and metabolic insights, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Use of continuous glucose monitoring (CGM) in diabetes management in Africa: opportunities, challenges, and future prospects.Cardiovascular diabetology. Endocrinology reports · 2026Review
- Younger Age is Associated with Treatment and Complication Outcomes Among Type 2 Diabetes Mellitus Patients in Kigali University Teaching Hospital.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Type 1 diabetes mellitus is associated with adverse maternal and neonatal outcomes. We aimed to evaluate the impact of CGM use on glycemic control and neonatal and maternal outcomes. Methods: This was a single-center study with prospective longitudinal data collection of pregnant women with T1DM allocated to 1 of 2 monitoring methods: Capillary blood monitoring and interstitial fluid glucose monitoring. Results: A total of 30 patients were enrolled. The average age was 31.26 ± 3.39 years, with an average gestational age of 9.4 ± 3.63 weeks at the first consultation. The average diabetes duration was 15.6 ± 7.36 years, with a mean preconception HbA1c of 8.67 ± 0.95%. The average BMI was 25 ± 2.88 kg/m Conclusion: Early implementation and sustained use of CGM in pregnant women with T1DM may optimize glucose control and mitigate maternal-fetal risks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.